Cheng Qi, Fan Chao, Liu Fengyun, Li Yuan, Hou Haiwen, Ma Yan, Tan Yueqing, Li Yuxian, Hai Yue, Wu Tianyi, Zhang Liangzhi, Zhang Yanming
Key Laboratory of Adaptation and Evolution of Plateau Biota, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining 810008, China; Qinghai Key Laboratory of Animal Ecological Genomics, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining 810008, China; University of Chinese Academy of Sciences, Beijing 100049, China.
National Key Laboratory of High Altitude Medicine, Qinghai High Altitude Medical Research Institute, Xining 810012, China; Qinghai Province Cardiovascular and Cerebrovascular Disease Specialist Hospital, Xining 810012, China.
Genomics. 2022 Nov;114(6):110483. doi: 10.1016/j.ygeno.2022.110483. Epub 2022 Sep 14.
The gut microbiota plays a crucial role in coronary heart disease (CHD). However, only a few studies focusing on the relationship between gut microbiota and CHD in ethnic populations are available. Here, we employed shotgun sequencing of the gut metagenome to analyze the taxonomic composition and functional annotation of the gut microbiota of 14 CHD patients, 13 patients with non-stenosis coronary heart disease (NCHD), and 18 healthy controls (HT) in Tibetan subjects. We found that the α-diversity of the gut microbiota was not significantly different among the three groups., whereas β-diversity was significantly altered in the CHD group compared with HT. Based on the receiver operating characteristic curve (ROC) analysis, the relative abundance of Proteobacteria species effectively distinguished patients with CHD from the control group. Most of the enriched species belonged to Proteobacteria. The pathways that contributed the most to the differences between groups were amino acid metabolism-related pathways, especially lysine biosynthesis. The enzymes of the lysine biosynthesis pathway, including K01714 and K00821, were significantly decreased in the CHD group. Our findings increase the understanding of the association between CHD pathogenesis and gut microbiota in the Tibetan population, thus paving the way for the development of improved diagnostic methods and treatments for Tibetan patients with CHD.
肠道微生物群在冠心病(CHD)中起着至关重要的作用。然而,目前仅有少数针对不同种族人群肠道微生物群与冠心病关系的研究。在此,我们采用鸟枪法对藏族受试者中14例冠心病患者、13例非狭窄性冠心病(NCHD)患者和18例健康对照(HT)的肠道宏基因组进行测序,以分析肠道微生物群的分类组成和功能注释。我们发现,三组之间肠道微生物群的α多样性无显著差异,而冠心病组与健康对照组相比,β多样性发生了显著改变。基于受试者工作特征曲线(ROC)分析,变形菌门物种的相对丰度能够有效区分冠心病患者与对照组。大多数富集物种属于变形菌门。对组间差异贡献最大的途径是氨基酸代谢相关途径,尤其是赖氨酸生物合成途径。冠心病组中赖氨酸生物合成途径的酶,包括K01714和K00821,显著减少。我们的研究结果增进了对藏族人群冠心病发病机制与肠道微生物群之间关联的理解,从而为改进藏族冠心病患者的诊断方法和治疗手段的开发铺平了道路。